Modification of piracetam’s nootropic action by phenibut, Bemitil and Sydnocarb
A. E. Kim · 2004 · Candidate dissertation author’s abstract, Saint Petersburg, 2004
What does this source report?
The transcribed author’s abstract describes human hypoxia, visuomotor training and pharmacokinetic comparisons, alongside animal work.
- Population and setting
- Several animal and human experiments; human study settings separated in the programme table
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Experiments within one dissertation are not independent programme replication.
- OCR gaps, small groups and incomplete allocation details limit appraisal.
- Combination exposure changes do not establish clinical synergy.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Author’s-abstract transcription
Review depth: Selected experiment methods
Related-report group: kim-combinations-programme. Reports in this group are not assumed to be independent trials.
Source access and review scope
Selected methods and experimental sections of a third-party transcription checked; original 122-page thesis not recovered.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Source provenance: Dissertation transcription
Cite and trace this record
Original source: A. E. Kim. Modification of piracetam’s nootropic action by phenibut, Bemitil and Sydnocarb Candidate dissertation author’s abstract, Saint Petersburg, 2004 2004.
Molekul research summary: https://molekul.io/research/kim-combinations-2004. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pirabel
The piracetam–Bemitil combination discussed in the 2019 fatigue monograph and earlier dissertation trail. The monograph attachment has been recovered; methods appraisal and independent replication remain pending.
Piracetam
Piracetam, marketed as Nootropil, connects the original nootropic concept with Soviet clinical adoption and later operator, hypoxia and maritime research. Healthy-volunteer experiments, clinical reviews and combination proposals answer different questions.
Bemitil
A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.